Sequential immune-targeted surgical therapy resulted in disease-free survival in a case with advanced renal cell carcinoma.
Kenichi NishimuraNoriyoshi MiuraNaoya SugiharaKeisuke FunakiKanae KoyamaYuichiro SawadaTerutaka NodaTetsuya FukumotoYuki MiyauchiTadahiko KikugawaTakashi SaikaMasafumi MatsumuraKatsuyoshi HashineMashio TaniwakiPublished in: BMC urology (2021)
This case suggests the utility of sequential immune-targeted therapy as neoadjuvant therapy in advanced renal cell carcinoma.